G1 Therapeutics Provides Third Quarter 2020 Corporate and Financial Update

NEXT STORY
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
AnaptysBio Announces Third Quarter 2020 Financial Results and Provides Pipeline Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Hemispherx Releases First 8,500 Vial Lot of Ampligen to Supply Expanded Access Programs in the United States, Europe and Canada for ME/CFS and Pancreatic Cancer and Announces Successful Finish of Second Commercial Size Lot

Balance for New Cancer Clinical Trials; Second Commercial-Size Batch Now in Regulatory TestingORLANDO, Fla., ...

author_avatar
NASDAQ Market News

Cellectar Biosciences Announces Recent Key Accomplishments and Second Quarter 2016 Financial Results

MADISON, Wis., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (“the company”), ...

author_avatar
NASDAQ Market News

Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus – Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors

author_avatar
NASDAQ Market News